According to new research, oestrogen therapy in postmenopausal women is associated with ventricular enlargement and increased white matter hyperintensities in the brain, but not with cognitive decline. This disconnect between structural and functional effects suggests that brain-derived lipids can be harnessed to meet the bioenergetic demand imposed by normal cognition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kantarci, K. et al. Effects of hormone therapy on brain structure: a randomized controlled trial. Neurology 87, 887–896 (2016).
Resnick, S. M. et al. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 72, 135–142 (2009).
Greenberg, D. L. et al. Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry Res. 147, 127–134 (2006).
Luoto, R. et al. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 48, 467–472 (2000).
Boccardi, M. et al. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause 13, 584–591 (2006).
Coker, L. H. et al. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies. Neurology 82, 427–434 (2014).
Rocca, W. A., Grossardt, B. R. & Shuster, L. T. Oophorectomy, estrogen, and dementia: a 2014 update. Mol. Cell. Endocrinol. 389, 7–12 (2014).
Brinton, R. D., Yao, J., Yin, F., Mack, W. J. & Cadenas, E. Perimenopause as a neurological transition state. Nat. Rev. Endocrinol. 11, 393–405 (2015).
Klosinski, L. P. et al. White matter lipids as a ketogenic fuel supply in aging female brain: implications for Alzheimer's disease. EBioMedicine 2, 1888–1904 (2015).
Rettberg, J. R. et al. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. Neurobiol. Aging 40, 155–163 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Brinton, R. Oestrogen therapy affects brain structure but not function. Nat Rev Neurol 12, 561–562 (2016). https://doi.org/10.1038/nrneurol.2016.147
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.147
This article is cited by
-
Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study
Molecular Neurobiology (2019)
-
Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging
Current Psychiatry Reports (2017)